Xin Xu, PhD, School of Public Health and The Second Affiliated Hospital of Zhejiang University, Hangzhou, China, discusses the HERITAGE trial (NCT05886114): a two-year, cluster randomized, controlled trial to determine the efficacy of several lifestyle interventions on elderly residents with a high risk of cognitive decline in China. This study is part of the World-Wide FINGERS network, which aims to determine the impact of employing the FINGER lifestyle intervention in elderly at-risk communities across the globe. Individuals between the ages of 60-80 years were suitable for the HERITAGE trial. Lifestyle interventions used include cognitive training and monitoring, physical exercise, diet monitoring, metabolic and vascular risk monitoring, and social isolation monitoring. Early data indicate that the elderly Chinese population are receptive to the interventions. The study is currently ongoing and has an estimated completion date of April 2025. This interview took place at the Alzheimer’s Association International Conference® (AAIC) 2023 in Amsterdam, Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.